Microenvironment of chronic lymphocytic leukaemia
Microenvironment of chronic lymphocytic leukaemia
Chronic lymphocytic leukaemia: Transition to a new era
The role of the microenvironment and novel therapies in CLL
Multi-target S-DNA increases colorectal cancer screening among previously non-compliant patients
p62: Metabolism and the tumour microenvironment
Targeted therapy shows continued promise in patients whose tumours had NTRK gene fusions
Editor's Choice for April 2016
Drugging “undruggable” transcription factor drivers in cancer
Elucidation and pharmacological targeting of tumour checkpoint dependencies
Metastasis intiation mediated by thrombospondin 2
New technology can potentially overcome CAR T-cell limitations
Germ line predisposition to leukaemia